BANGALORE, June 19 (Reuters) - Drugmaker Jazz Pharmaceuticals Inc (JAZZ.O) has put the development of three drugs in its pipeline on hold, in a bid to save cash as it seeks to resolve interest payment issues with its bond holders, a company spokesman said.
